Institutional decision to adopt Y90 as primary treatment for hepatocellular carcinoma informed by a 1,000‐patient 15‐year experience-Reference-Cited by-同舟云学术

Institutional decision to adopt Y90 as primary treatment for hepatocellular carcinoma informed by a 1,000‐patient 15‐year experience

Published:2018-01-29 Issue:4 Volume:68 Page:1429-1440
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Salem Riad¹²³^ORCID,Gabr Ahmed¹^ORCID,Riaz Ahsun¹,Mora Ronald¹,Ali Rehan¹,Abecassis Michael³^ORCID,Hickey Ryan¹,Kulik Laura⁴,Ganger Daniel⁴,Flamm Steven⁴,Atassi Rohi¹,Atassi Bassel¹,Sato Kent¹,Benson Al B.²,Mulcahy Mary F.²,Abouchaleh Nadine¹,Asadi Ali Al¹,Desai Kush¹,Thornburg Bartley¹,Vouche Michael¹,Habib Ali¹,Caicedo Juan³,Miller Frank H.⁵,Yaghmai Vahid⁵,Kallini Joseph R.¹,Mouli Samdeep¹,Lewandowski Robert J.¹²³

Affiliation:

1. Department of Radiology, Section of Interventional RadiologyNorthwestern University Chicago IL

2. Department of Medicine, Division of Hematology and OncologyNorthwestern University Chicago IL

3. Department of Surgery, Division of Transplant SurgeryNorthwestern University Chicago IL

4. Department of Medicine, Division of HepatologyNorthwestern University Chicago IL

5. Department of Radiology, Section of Body ImagingNorthwestern University Chicago IL

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.29691

Reference31 articles.

1. Global cancer statistics, 2012

2. EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma

3. NCCN Guidelines Insights: Hepatobiliary Cancers, Version 1.2017

4. Radioembolization with 90Yttrium Microspheres: A State-of-the-Art Brachytherapy Treatment for Primary and Secondary Liver Malignancies

5. Unresectable solitary hepatocellular carcinoma not amenable to radiofrequency ablation: Multicenter radiology-pathology correlation and survival of radiation segmentectomy

Cited by 178 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Term Overall Survival After Selective Internal Radiation Therapy for Locally Advanced Hepatocellular Carcinomas: Updated Analysis of DOSISPHERE-01 Trial;Journal of Nuclear Medicine;2024-01-11

2. Lineage-specific regulation of PD-1 expression in early-stage hepatocellular carcinoma following 90yttrium transarterial radioembolization – Implications in treatment outcomes;European Journal of Cancer;2024-01

3. Management of Intermediate-Stage Hepatocellular Carcinoma;Surgical Oncology Clinics of North America;2024-01

4. INASL Consensus on Management of HCC: Navigating an Evolving Field;Journal of Clinical and Experimental Hepatology;2024-01

5. Radioembolisation mit Harz- und Glas-Mikrosphären;Angewandte Nuklearmedizin;2023-12